Meningitis In Elderly Patients
Published on: February 23, 2025
meningitis in elderly patients
Article author photo

Aviksha Gajendra Premanandha

MSc. Food Systems and Management, <a href="https://www.cranfield.ac.uk/som" rel="nofollow">Cranfield University, United Kingdom</a>

Article reviewer photo

Parul Vakada

MSc Clinical Drug Development, QMUL

Introduction

Definition and types of meningitis

Meningitis is an inflammation of the protective membranes covering the brain and spinal cord, collectively known as the meninges. The inflammation is usually caused by an infection of the fluid surrounding the brain and spinal cord. Meningitis can be categorised into three primary types:

  1. Bacterial Meningitis: Caused by bacteria such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. This type is typically severe and can be life-threatening without prompt treatment
  2. Viral Meningitis: Caused by viruses such as enteroviruses, herpes simplex virus, and West Nile virus. It is generally less severe than bacterial meningitis and often resolves without specific treatment
  3. Fungal Meningitis: Caused by fungi like Cryptococcus neoformans and Histoplasma. This type is less common and usually affects individuals with weakened immune systems

Importance in elderly patients

Elderly patients are particularly vulnerable to meningitis due to several factors. Age-related decline in immune function, presence of comorbidities (such as diabetes, renal failure, or chronic obstructive pulmonary disease), and increased likelihood of residing in communal living environments (such as nursing homes) contribute to their heightened risk. The elderly are also more likely to experience severe complications, prolonged recovery, and higher mortality rates compared to younger populations.1

Objectives: epidemiology, symptoms, diagnosis, treatment, prevention

  • Understand the epidemiology of meningitis in elderly patients
  • Identify symptoms and diagnostic methods specific to this age group
  • Explore treatment options and preventive measures tailored for elderly patients2

Epidemiology

Prevalence and incidence rates

The incidence of meningitis varies globally and among different age groups. Elderly individuals, particularly those over 65 years of age, exhibit higher rates of meningitis compared to younger populations. For example, studies have shown that the incidence rate of bacterial meningitis in the elderly can range from 3 to 10 cases per 100,000 individuals annually, which is significantly higher than in younger adults. Viral meningitis, while less common in the elderly compared to bacteria, still presents a notable health risk due to the increased susceptibility of this age group to viral infections.

Risk factors: weakened immunity, chronic diseases, communal living

  • Weakened Immunity: Aging leads to immunosenescence, a gradual decline in immune function, making the elderly more susceptible to infections, including meningitis
  • Chronic Diseases: Conditions such as diabetes, renal failure, and chronic lung diseases compromise the body's ability to fight infections effectively
  • Communal Living: Environments such as nursing homes and assisted living facilities increase the risk of exposure to infectious agents due to close contact with other residents and healthcare workers 

Common causative agents: bacterial, viral, fungal

Bacterial: The most common bacterial pathogens causing meningitis in the elderly include Streptococcus pneumoniae, Neisseria meningitidis, and Listeria monocytogenes. These bacteria can enter the bloodstream and cross the blood-brain barrier, leading to inflammation of the meninges.3

Viral: Viruses such as enteroviruses, herpes simplex virus (HSV), and varicella-zoster virus (VZV) are notable causes of viral meningitis in the elderly. The reactivation of latent viruses (e.g., HSV and VZV) can be more frequent in older adults due to weakened immune systems.

Fungal: Fungal meningitis, although rare, can affect elderly individuals with compromised immune systems. Cryptococcus neoformans and Histoplasma capsulatum are the primary fungi responsible for fungal meningitis in this population.4

Symptoms and clinical presentation

General symptoms: fever, headache, neck stiffness

Fever: Fever is one of the hallmark signs of meningitis, reflecting the body's immune response to infection.

Headache: Severe and persistent headaches are common due to the inflammation of the meninges.

Neck Stiffness: Stiff neck, or nuchal rigidity, occurs due to irritation of the meninges, making neck movement painful.

Elderly-specific symptoms: confusion, less pronounced fever, seizures

Confusion: Cognitive changes, such as confusion, delirium, and decreased consciousness, are more frequent in elderly patients. These symptoms can be primary indicators of meningitis in this age group.

Less Pronounced Fever: Elderly patients may not exhibit a significant rise in temperature due to a less vigorous immune response, often leading to a less pronounced fever or even normothermia.

Seizures: Seizures can occur more frequently in elderly patients, indicating severe inflammation or increased intracranial pressure.

Challenges: atypical presentation, overlap with other conditions

Atypical Presentation: Elderly patients often present with non-specific or atypical symptoms, making it challenging to recognize meningitis early. Symptoms such as lethargy, malaise, or general decline in function can be misleading.5

Overlap with Other Conditions: The symptoms of meningitis in elderly patients can overlap with other common conditions in this age group, such as dementia, stroke, or urinary tract infections, complicating the diagnostic process.

Diagnosis

Initial assessment: history, physical exam

History: A comprehensive medical history is critical, including recent infections, comorbid conditions, and any potential exposure to infectious agents. Assessing the patient's vaccination status and history of chronic illnesses can provide valuable context.

Physical Exam: A thorough physical examination, including a neurological assessment, is essential to identify signs of meningitis6. This may involve checking for nuchal rigidity, photophobia, and performing specific manoeuvres like Kernig's and Brudzinski's signs.

Diagnostic tests: lumbar puncture, blood tests, imaging

Lumbar Puncture (LP): Performing a lumbar puncture is crucial for diagnosing meningitis. Cerebrospinal fluid (CSF) analysis helps identify the causative pathogen and differentiates between bacterial, viral, and fungal infections.

  • CSF Appearance: Bacterial meningitis often results in turbid CSF, whereas viral and fungal infections may present with clear CSF
  • CSF Composition: Elevated white blood cell count, increased protein levels, and decreased glucose levels are indicative of bacterial meningitis. Viral meningitis typically shows a moderate increase in white blood cells with normal glucose levels, while fungal infections can present with elevated white cells and protein levels, and decreased glucose

Blood Tests: Blood tests, including complete blood count (CBC) and blood cultures, are essential for detecting systemic infection and identifying the causative organism.

Imaging: Imaging studies, such as a CT scan or magnetic resonance imaging (MRI) of the head, are performed to rule out other conditions like abscesses, tumours, or increased intracranial pressure, and to assess for complications associated with meningitis.

Differential diagnosis: other causes of altered mental status, coexisting infections

Other Causes of Altered Mental Status: Differential diagnosis should include other potential causes of altered mental status, such as stroke, encephalitis, metabolic imbalances (e.g., hypoglycemia), and toxic encephalopathy. These conditions can present with similar symptoms and need to be ruled out .

Coexisting Infections: Identifying and managing coexisting infections, such as urinary tract infections, pneumonia, or septicemia, is crucial as they can complicate the clinical picture and impact treatment decisions7.

Treatment

Initial management: empiric antibiotics, antiviral/antifungal treatments

Empiric Antibiotics: Immediate administration of broad-spectrum antibiotics is crucial once bacterial meningitis is suspected, even before the causative organism is identified. Common empiric regimens include a combination of vancomycin and a third-generation cephalosporin (e.g., ceftriaxone or cefotaxime). In elderly patients, ampicillin is often added to cover Listeria monocytogenes due to their increased susceptibility to this pathogen.

Antiviral Treatments: If viral meningitis is suspected, particularly caused by HSV, empirical antiviral therapy with acyclovir is initiated until HSV is ruled out by CSF PCR testing.

Antifungal Treatments: For fungal meningitis, especially in immunocompromised elderly patients, antifungal medications such as amphotericin B and flucytosine are used, followed by fluconazole for maintenance therapy once the diagnosis is confirmed.

Supportive care: hospitalisation, managing complications

Hospitalisation: Elderly patients with meningitis often require hospitalisation for close monitoring, administration of intravenous medications, and supportive care. This includes fluid management, ensuring adequate hydration, and maintaining electrolyte balance.

Managing Complications: Complications such as increased intracranial pressure, seizures, and shock are managed with appropriate interventions. Corticosteroids, like dexamethasone, may be administered to reduce inflammation and prevent neurological damage in bacterial meningitis. Anticonvulsants are used to control seizures.9

Long-term outcomes: recovery, monitoring long-term effects

Recovery: Recovery from meningitis in elderly patients can be prolonged and may require extensive rehabilitation. Physical, occupational, and speech therapies are often necessary to address deficits that may result from the infection.

Monitoring Long-term Effects: Long-term follow-up is crucial to monitor for potential complications such as hearing loss, cognitive impairment, and motor deficits. Regular assessments and supportive measures are needed to manage these outcomes and improve the quality of life for affected individuals8.

Prevention

Vaccination: pneumococcal, meningococcal, influenza

Pneumococcal Vaccines: Vaccination with pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) is recommended for elderly individuals to prevent pneumococcal meningitis.

Meningococcal Vaccines: Elderly patients, especially those in communal living settings or with certain medical conditions, should receive meningococcal vaccines (MenACWY and MenB) to protect against meningococcal disease.10

Influenza Vaccine: Annual influenza vaccination is important as it reduces the risk of secondary bacterial infections, including meningitis, following influenza infection.

Infection control: hygiene, avoiding communal exposure

Hygiene: Proper hand hygiene and respiratory etiquette are essential to prevent the spread of infectious agents that can cause meningitis. Regular handwashing and the use of alcohol-based hand sanitizers are effective measures.

Avoiding Communal Exposure: Limiting exposure to crowded and communal environments, especially during outbreaks, helps reduce the risk of contracting meningitis-causing pathogens.

Prophylactic antibiotics: for close contacts, high-risk situations

For Close Contacts: Prophylactic antibiotics, such as rifampin, ciprofloxacin, or ceftriaxone, are recommended for close contacts of patients with meningococcal meningitis to prevent the spread of infection.

High-risk Situations: Prophylactic antibiotics are also advised for individuals in high-risk situations, such as during outbreaks in communal settings (e.g., nursing homes) or for those with immunocompromising conditions that increase their susceptibility to infections.11

Summary

Meningitis, an inflammation of the meninges covering the brain and spinal cord, is particularly concerning in elderly patients due to their heightened vulnerability. This inflammation, often caused by an infection, is classified into three main types: bacterial, viral, and fungal. Bacterial meningitis, caused by pathogens like Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae, is severe and life-threatening without prompt treatment. Viral meningitis, caused by enteroviruses, herpes simplex virus, and West Nile virus, is generally less severe and often resolves without specific treatment.

Fungal meningitis, caused by fungi such as Cryptococcus neoformans and Histoplasma, is less common and usually affects those with weakened immune systems. Elderly individuals are at a higher risk due to age-related immune decline, comorbidities like diabetes and renal failure, and increased exposure in communal living environments, leading to severe complications and higher mortality rates. The prevalence of meningitis is higher in this age group, with bacterial meningitis rates ranging from 3 to 10 cases per 100,000 annually. Common symptoms include fever, headache, and neck stiffness, but elderly-specific symptoms like confusion, less pronounced fever, and seizures can complicate diagnosis due to atypical presentations and symptom overlap with other conditions.

Diagnosis involves a thorough medical history, physical examination, lumbar puncture to analyze cerebrospinal fluid, blood tests, and imaging to rule out other conditions and assess complications. Treatment begins with empiric antibiotics for bacterial meningitis, antivirals for viral infections, and antifungal medications for fungal meningitis, alongside supportive care that includes hospitalization and managing complications. Long-term outcomes require monitoring for potential complications like hearing loss and cognitive impairment. Preventive measures are crucial and include vaccinations against pneumococcal and meningococcal diseases and annual influenza vaccines, alongside infection control practices and prophylactic antibiotics for those at high risk or close contacts with infected individuals. Effective prevention and early treatment are essential to mitigate the impact of meningitis in elderly patients.

References

  • Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases [Internet]. 2004 Nov 1 [cited 2024 Jul 2];39(9):1267–84. Available from: https://academic.oup.com/cid/article/39/9/1267/402080 
  • Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010 Jul;23(3):467–92. Available from: 10.1128/CMR.00070-09
  • van de Beek D, de Gans J, Tunkel AR, Wijdicks EFM. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006 Jan 5;354(1):44–53. Available from: 10.1056/NEJMra052116 
  • Schut ES, Lucas MJ, Brouwer MC, Vergouwen MDI, van der Ende A, van de Beek D. Cerebral infarction in adults with bacterial meningitis. Neurocrit Care. 2012 Jun;16(3):421–7. Available from: 10.1007/s12028-011-9634-4 
  • Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, et al. Bacterial meningitis in the United States, 1998–2007. N Engl J Med [Internet]. 2011 May 26 [cited 2024 Jul 2];364(21):2016–25. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1005384 
  • Kupila L, Vuorinen T, Vainionpää R, Hukkanen V, Marttila RJ, Kotilainen P. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology. 2006 Jan 10;66(1):75–80. Available form: 10.1212/01.wnl.0000191407.81333.00
  • CDC. Meningitis. 2024 [cited 2024 Jul 2]. Meningitis. Available from: https://www.cdc.gov/meningitis/index.html 
  • Gavazzi G, Krause KH. Ageing and infection. The Lancet Infectious Diseases [Internet]. 2002 Nov 1 [cited 2024 Jul 2];2(11):659–66. Available from: https://www.sciencedirect.com/science/article/pii/S1473309902004371 
  • Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010 Feb 1;50(3):291–322. Available from: 10.1086/649858 
  • Łyczko K, Borger J. Meningococcal prophylaxis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jul 2]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK537338/ 
  • Meningitis [Internet]. [cited 2024 Jul 2]. Available from: https://www.who.int/news-room/fact-sheets/detail/meningitis 

Share

Aviksha Gajendra Premanandha

MSc. Food Systems and Management, Cranfield University, United Kingdom

With a strong academic foundation in food systems, management, life sciences and practical experience in clinical investigation, microbiological analysis and innovative project involvement, I bring a multidisciplinary skillset to research endeavours.

An accomplished graduate with expertise spanning food safety, quality management, agri-food business innovation, postharvest technology, and food diagnostics.

Committed to leveraging my knowledge to contribute to meaningful research centre on enhancing human, plant, animal and environmental wellbeing.

I have published in peer-reviewed journals, presented at conferences, and filed a patent demonstrating my research acumen. Additionally, I have received multiple awards and scholarships recognizing my academic excellence.

With laboratory skills, data analysis capabilities and a passion for mentorship, I am well equipped to tackle complex challenges through insightful research.

arrow-right